We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNTK icon
14151
State Street SPDR NYSE Technology ETF
XNTK
$2.27B
-20,837
Closed -$2.9M
XOSWW
14152
Xos Inc Warrants
XOSWW
$9.72K
-115,000
Closed -$49K
XPEL icon
14153
XPEL
XPEL
$1.39B
-11,902
Closed -$562K
XPH icon
14154
CALL
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
-9,200
Closed -$416K
XRLV
14155
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
-4,259
Closed -$215K
XSHQ icon
14156
Invesco S&P SmallCap Quality ETF
XSHQ
$323M
-5,602
Closed -$202K
XSOE icon
14157
PUT
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.12B
-10,000
Closed -$327K
XTJA icon
14158
Innovator US Equity Accelerated Plus ETF January
XTJA
$20.9M
-15,500
Closed -$369K
XTN icon
14159
State Street SPDR S&P Transportation ETF
XTN
$398M
-2,840
Closed -$253K
XVV icon
14160
iShares ESG Screened S&P 500 ETF
XVV
$682M
-14,580
Closed -$501K
XWEL icon
14161
XWELL
XWEL
$8.53M
-5,409
Closed -$95.1K
YLD icon
14162
Principal Active High Yield ETF
YLD
$584M
-16,341
Closed -$326K
YMAB
14163
DELISTED
Y-mAbs Therapeutics
YMAB
-26,927
Closed -$314K
YOLO icon
14164
CALL
AdvisorShares Pure Cannabis ETF
YOLO
$33.8M
-14,500
Closed -$155K
YORW icon
14165
CALL
York Water
YORW
$536M
-5,100
Closed -$229K
YSG
14166
Yatsen Holding
YSG
$319M
-90,045
Closed -$306K
ZD icon
14167
CALL
Ziff Davis
ZD
$1.92B
-4,700
Closed -$455K
ZD icon
14168
Ziff Davis
ZD
$1.92B
-181,152
Closed -$15M
ZEPP
14169
PUT
Zepp Health
ZEPP
$78.6M
-3,550
Closed -$41K
ZGN icon
14170
Zegna
ZGN
$3.73B
-14,748
Closed -$156K
ZIG icon
14171
The Acquirers Fund
ZIG
$32.6M
-9,445
Closed -$271K
ZROZ icon
14172
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.31B
-41,708
Closed -$4.68M
ZUMZ icon
14173
CALL
Zumiez
ZUMZ
$319M
-12,700
Closed -$485K
ZWS icon
14174
CALL
Zurn Elkay Water Solutions
ZWS
$8.41B
-7,400
Closed -$262K
ZYME icon
14175
PUT
Zymeworks
ZYME
$1.83B
-26,000
Closed -$170K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.